Tonix Pharma
TNXP----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Tonix Pharma(TNXP) predict that the Revenue is 6.878 M (+183.2%), Miss estimate;the EBIT is -41.54 M (-158.7%), Miss estimate;the EPS is -2.93 (-3.17%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.01B183.16%
0.01B186.13%
-0.00B2.97%
EBITMiss expectations
-0.04B158.73%
-0.04B144.18%
-0.00B14.55%
EPSMiss expectations
-2.933.17%
-2.433314.32%
-0.496717.49%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf